As of the close on March 14, 2025, BioMarin Pharmaceutical Inc.'s stock has declined approximately 17.66% over the past 52 weeks. The 50-day moving average sits at 63.22, while the 200-day moving average is 68.75.
| 52-Week Price Change | -17.66% |
| 50-Day Moving Average | 63.22 |
| 200-Day Moving Average | 68.75 |